Imaging of regional lymph node metastases with 99mTc-depreotide in patients with lung cancer

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 8, 2005, Pages 925-931

  Danielsson, Rimma ^a   Bååth, Margaretha ^a   Svensson, Leif ^a   Forslöv, Ulrica ^a   Kölbeck, Karl Gustav ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

99mTc depreotide; Lung cancer; Lymph nodes; Radionuclide imaging; Somatostatin

Indexed keywords

DEPREOTIDE TC 99M; TRACER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN;

EID: 23944463514     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1800-5     Document Type: Article

References (16)

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7.
2. Webb WR, Catsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis IR. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178:705-13.
3. Ho Shon I, O' Doherty MJ, Maisey MN. Positron emission tomography in lung cancer. Semin Nuclear Med 2003;XXXII(4):240-71.
4. Blum J, Handmaker H, Lister-James J, Rinne N, NeoTect Solitary Pulmonary Nodule Study Group. A multicenter trial with a somatostatin analog 99m-Tc depreotide in the evaluation of solitary pulmonary nodules. Chest 2000;117:1232-8.
5. Reubi JC, Laissue J, Krenning EP, Lamberts SWJ. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical application. J Steroid Biochem Mol Biol 1992;43:27-35.
6. O'Byrne KJ, Carney DN. Somatostatin and the lung. Lung Cancer 1993;10:151-72.
7. 99mTc-P829. Cancer Res 1998;58:1850-9.
8. Menda Y, Kahn D, Bushnell DL, Thomas M, Miller S, McLaughlin K, et al. Non-specific mediastinal uptake of 99m-Tc depreotide (NeoTect™). J Nucl Med 2001;42:304P.
9. Grewal RK, Dadparvar S, Yu JQ, Babaria CJ, Cavanaugh T, Sherman M, et al. Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules. Cancer J 2002;8(5):400-4.
10. Tcherniantchouk O, Waxman AD, Williams CM, Kononov Y, Alsabeh R, 'Agnolo D, et al. Evaluation of hilar and mediastinal lymph nodes with Tc-99m depreotide in lung cancer: detection of micrometastases. J Nucl Med 2003;44:Suppl, abstract 440.
11. 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer. Chest 2004;125:494-501.
12. Menda Y, Khan D. Somatostatin receptor imaging of non-small cell lung cancer with 99m-Tc depreotide. Semin Nucl Med 2002;XXXII:92-6.
13. DeVita VT, Hellman S, Rosemberg SA. Cancer. Principles and practice of oncology. Philadelphia: J.B. Lippincott; 1982.
14. Van Hagen PM, Krenning EP, Kwekkeboom DJ, Reubi JC, Anker-Lugtenburg PJ, Löwenberg B, et al. Somatostatin and the immune and haematopoietic system; a review. Eur J Clin Investig 1994;24:91-9.
15. Shih W-J, Samayoa L. Tc-99m depreotide detecting malignant pulmonary nodules. Histopathologic correlation with semiquantitative tumour-to-normal lung ratio. Clin Nucl Med 2004;29:171-6.
16. Bushnell D, Menda Y, Madsen M, Link B, Kahn D, Truhlar S, et al. 99m-Tc-depreotide tumour uptake in patients with non-Hodgkin's lymphoma. Nucl Med Commun 2004;25:839-43.